It's no secret that the U.S. elderly population is only growing, and with that will be an increased prevalence of
The Milken Institute Center for the Future of Aging, an independent economic think tank, found that the prevalence of Alzheimer's Disease and related dementias (or ADRD) treatment has soared, with costs increasing by 31% since 2012, totaling to $60.3 billion last year. However, women and people of color may find themselves at a disproportionate risk for dementia and the financial burden that comes with it.
"Almost two-thirds of people with Alzheimer's are women," says Diane Ty, director at the Milken Institute Center for the Future of Aging. "And communities of color are disproportionately affected by Alzheimer's and related dementias, but they're just not being diagnosed."
Read more:
While dementia mostly impacts people who are 75 and up, and likely retired, Ty argues that employers should be aware of what this disease costs caregivers and how education and prevention can lower the number of elderly Americans who are impacted by deterioration in cognitive function.
Here are five things employers should know about the prevalence and cost of ADRD, according to the